Flare Therapeutics Stock
HealthTechLooking to sell Flare Therapeutics stock or options?
Flare Therapeutics is a health-tech company focused on developing small-molecule precision medicines for cancer patients. Their platform is adept at targeting transcription factors to identify precision treatments for neurology, rare genetic disorders, immunology, and inflammation. This enables healthcare professionals to alter the course of disease treatment effectively.
Investors Include:
ShangBay Capital, Eli Lilly and Company, Eventide Asset Management, Agent Capital, Third Rock Ventures, Invus Financial Advisors, Nextech Invest, Boxer Capital, Pavilion Capital Partners, Memorial Sloan Kettering Cancer Center, Pfizer Ventures, Novartis, Casdin Capital, GordonMD Global Investments.